[HTML][HTML] Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity

GA Kim, JH Moon, W Kim - Clinical and molecular hepatology, 2023 - ncbi.nlm.nih.gov
The existing term non-alcoholic fatty liver disease (NAFLD) has raised substantial concerns
due to its inherent disadvantages of using exclusionary diagnostic criteria and the …

Steatotic liver disease: metabolic dysfunction, alcohol, or both?

K Staufer, RE Stauber - Biomedicines, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD), both of
them accounting for fatty liver disease (FLD), are among the most common chronic liver …

[HTML][HTML] A global action agenda for turning the tide on fatty liver disease

JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri… - Hepatology, 2024 - journals.lww.com
Conclusions: This consensus-driven multidisciplinary fatty liver disease action agenda
developed by care providers, clinical researchers, and public health and policy experts …

Opportunities and challenges following approval of resmetirom for MASH liver disease

JV Lazarus, D Ivancovsky Wajcman, HE Mark… - Nature Medicine, 2024 - nature.com
Opportunities and challenges following approval of resmetirom for MASH liver disease | Nature
Medicine Skip to main content Thank you for visiting nature.com. You are using a browser …

[HTML][HTML] A narrative review about cognitive impairment in Metabolic Dysfunction–Associated Liver Disease (MASLD): Another matter to face through a holistic …

M Meroni, M Longo, E Paolini, P Dongiovanni - Journal of Advanced …, 2024 - Elsevier
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most
common chronic hepatic disorder worldwide in both adults and children. It is well …

It is time to expand the fatty liver disease community of practice

JV Lazarus, CJ Kopka, ZM Younossi, AM Allen - Hepatology, 2023 - journals.lww.com
An estimated 1 in 3 adults [1]—and 1 in 8 children [2]—worldwide have the form of chronic
liver disease presently known as NAFLD.[3] NAFLD is associated with an increased risk of …

Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk …

MG Taru, M Lupsor-Platon - Cancers, 2023 - mdpi.com
Simple Summary Non-alcoholic fatty liver disease (NAFLD) has become a significant public
health concern, affecting over 30% of the population. The incidence of NAFLD-related …

Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition …

Z Tan, Y Wu, Y Meng, C Liu, B Deng, J Zhen, W Dong - Nutrients, 2023 - mdpi.com
Background: Most studies have primarily focused on assessing the association between diet
or exercise patterns and metabolic dysfunction-associated steatotic liver disease (MASLD) …

[HTML][HTML] The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement

H Hagström, LA Adams, AM Allen… - Hepatology …, 2024 - journals.lww.com
Background: Following the adoption of new nomenclature for steatotic liver disease, we
aimed to build consensus on the use of International Classification of Diseases codes and …

[HTML][HTML] The burden of liver disease in Latin America

LA Díaz, M Villota-Rivas, F Barrera, JV Lazarus… - Annals of …, 2024 - Elsevier
Liver disease poses a substantial burden in Latin America. This burden is primarily
attributed to a high level of alcohol consumption and the increasing prevalence of risk …